Shen Yvonne Y, Hughes Jaquelyne T, Charlesworth John A, Kelly John J, Peake Philip W
Department of Nephrology, Prince of Wales Hospital, Sydney, New South Wales, Australia.
Nephrology (Carlton). 2008 Oct;13(5):405-10. doi: 10.1111/j.1440-1797.2008.00949.x. Epub 2008 Jun 2.
To determine whether adiponectin detected in urine is present in its native form and if adiponectin receptors (AdipoR) present and functional in proximal tubular (HK-2) cells.
Adiponectin is a protein with anti-inflammatory, anti-atherogenic and insulin-sensitizing properties. It has previously been detected antigenically in the urine in several forms of renal disease.
We compared the isoform distribution of urinary adiponectin in patients with proteinuric and non-proteinuric renal disease with that of matched controls using chromatography and enzyme-linked immunosorbent assay. We examined whether AdipoR were present in HK-2 cells by real-time reverse transcription polymerase chain reaction. Their functionality was investigated by determining the effect of recombinant adiponectin on adenosine monophosphate-activated protein kinase phosphorylation using western blotting, and on the secretion of monocyte chemotactic protein-1 and C3 using enzyme-linked immunosorbent assays.
Adiponectin in the urine is physiologically intact and largely present as the low molecular weight isoform. Subjects with urinary protein >150 mg/L excreted significantly more adiponectin and its high and low molecular weight isoforms than those with <150 mg/L. mRNA for AdipoR were present in HK-2 cells, with levels of mRNA for AdipoR1 being 20 times greater than those for AdipoR2. Ligation of AdipoR on proximal tubular cells increased phosphorylation of adenosine monophosphate-activated protein kinase, and downregulated the secretion of the inflammatory cytokine monocyte chemotactic protein-1, but not of C3.
Physiologically relevant isoforms of adiponectin are present in the urine of normal subjects and those with proteinuria. In addition, functional receptors for adiponectin are present in HK-2 cells. Abnormal levels of adiponectin in the urine may therefore activate these receptors, potentially resulting in anti-inflammatory activity.
确定尿液中检测到的脂联素是否以天然形式存在,以及脂联素受体(AdipoR)在近端肾小管(HK - 2)细胞中是否存在并具有功能。
脂联素是一种具有抗炎、抗动脉粥样硬化和胰岛素增敏特性的蛋白质。此前已在多种肾脏疾病的尿液中通过抗原检测发现了它。
我们使用色谱法和酶联免疫吸附测定法,比较了蛋白尿性和非蛋白尿性肾脏疾病患者尿液中脂联素的异构体分布与匹配对照组的情况。我们通过实时逆转录聚合酶链反应检测HK - 2细胞中是否存在AdipoR。通过蛋白质印迹法测定重组脂联素对腺苷单磷酸激活蛋白激酶磷酸化的影响,以及通过酶联免疫吸附测定法测定其对单核细胞趋化蛋白 - 1和C3分泌的影响,来研究它们的功能。
尿液中的脂联素在生理上是完整的,并且主要以低分子量异构体形式存在。尿蛋白>150 mg/L的受试者比尿蛋白<150 mg/L的受试者排泄的脂联素及其高分子量和低分子量异构体明显更多。HK - 2细胞中存在AdipoR的mRNA,其中AdipoR1的mRNA水平比AdipoR2高20倍。近端肾小管细胞上AdipoR的连接增加了腺苷单磷酸激活蛋白激酶的磷酸化,并下调了炎性细胞因子单核细胞趋化蛋白 - 1的分泌,但未影响C3的分泌。
正常受试者和蛋白尿患者的尿液中存在生理相关的脂联素异构体。此外,HK - 2细胞中存在脂联素的功能性受体。因此,尿液中脂联素水平异常可能会激活这些受体,从而可能产生抗炎活性。